Actively Recruiting
Optimization of ITBS for Depression
Led by Université de Sherbrooke · Updated on 2025-02-10
30
Participants Needed
1
Research Sites
99 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Repetitive TMS (rTMS) is a well-established method for modulating brain activity. Through successive stimulations in the form of magnetic fields, it is possible to modify the sensitivity of neurons in the brain, also known as cortical excitability. Cortical excitability is important for the induction of brain plasticity, the ability of the brain to reorganize itself and form new connections in response to stimuli. A particular class of rTMS, intermittent theta burst TMS (iTBS), is commonly used to modulate cortical excitability and induce plasticity for therapeutic purposes, notably for treatment-resistant depression. Different iTBS stimulation parameters can be used to induce plasticity. This study will focus on two parameters, namely, the form and duration of the electromagnetic stimulation. The shape of the electromagnetic pulse refers to how the electromagnetic wave is configured over time, while the duration is simply the period during which this electromagnetic pulse remains active. These parameters are expected to influence the effectiveness of iTBS in modulating cortical activity but remain little studied. The main aim of this study will be to compare the effectiveness of different stimulation parameters in the induction of plasticity, which will then make it possible to improve the rTMS protocols used for treatment-resistant depression.
CONDITIONS
Official Title
Optimization of ITBS for Depression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be between 18 and 35 years old
- Be of right manual dominance
- Be in good health
You will not qualify if you...
- Have an implant or pacemaker
- Having tinnitus
- Have a history of fainting
- Have had an epileptic seizure or have a family history of epilepsy
- Have a known neurological disease
- Be under psychotropic medication
- Have suffered from substance abuse or dependence in the last 6 months
- Have a neurostimulator
- Have a splinter or metallic implant in the head or the rest of the body
- Have a cochlear implant
- Have an automated injection system implanted (insulin pump)
- Have a transdermal patch
- Have tattoos in the area to be studied
- Be pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre de recherche du Centre hospitalier universitaire de Sherbrook
Sherbrooke, Quebec, Canada, J1H 5H3
Actively Recruiting
Research Team
S
Samantha Cote, Ph.D.
CONTACT
J
Jean-Francois Lepage, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here